Literature DB >> 11903301

Glucocorticoid-induced hypertension: from mouse to man.

J A Whitworth1, C G Schyvens, Y Zhang, G J Mangos, J J Kelly.   

Abstract

1. Adrenocorticotrophic hormone (ACTH) raises blood pressure in humans, sheep, rat and mouse. In rat and humans, but not sheep, the hypertension can be explained by glucocorticoid excess. 2. In both rat and humans, the hypertension is associated with a rise in cardiac output and renal vascular resistance. 3. In both rat and humans, the nitric oxide system is implicated in glucocorticoid hypertension. 4. In both rat and humans, hypertension due to naturally occurring glucocorticoids is not prevented by drugs that block classical glucocorticoid or mineralocorticoid receptors. 5. Abnormalities in glucocorticoid metabolism may contribute to some forms of 'essential' hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11903301     DOI: 10.1046/j.1440-1681.2001.03584.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  14 in total

1.  ACTH-induced hypertension is dependent on the ouabain-binding site of the alpha2-Na+-K+-ATPase subunit.

Authors:  John N Lorenz; Elizabeth L Loreaux; Iva Dostanic-Larson; Valerie Lasko; J Renee Schnetzer; Richard J Paul; Jerry B Lingrel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-16       Impact factor: 4.733

Review 2.  Corticosteroid-induced adverse events in adults: frequency, screening and prevention.

Authors:  Laurence Fardet; Abdulrhaman Kassar; Jean Cabane; Antoine Flahault
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 3.  Role of the brain melanocortins in blood pressure regulation.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Taolin Fang; Nicola Aberdein; Cecilia E Perez de Lara; John E Hall
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-06       Impact factor: 5.187

Review 4.  Loneliness matters: a theoretical and empirical review of consequences and mechanisms.

Authors:  Louise C Hawkley; John T Cacioppo
Journal:  Ann Behav Med       Date:  2010-10

Review 5.  [Adrenal cortex and steroids. Supplementary therapy in the perioperative phase].

Authors:  A S Milde; B W Böttiger; M Morcos
Journal:  Anaesthesist       Date:  2005-07       Impact factor: 1.041

6.  Thyroid hormone activation in vascular smooth muscle cells is negatively regulated by glucocorticoid.

Authors:  Nagaoki Toyoda; Saori Yasuzawa-Amano; Emiko Nomura; Azusa Yamauchi; Kumiko Nishimura; Chizuko Ukita; Satoshi Morimoto; Atsushi Kosaki; Toshiji Iwasaka; John W Harney; P Reed Larsen; Mitsushige Nishikawa
Journal:  Thyroid       Date:  2009-07       Impact factor: 6.568

7.  Glucocorticoid treatment impairs microvascular function in healthy men in association with its adverse effects on glucose metabolism and blood pressure: a randomised controlled trial.

Authors:  Daniël H van Raalte; Michaela Diamant; D Margriet Ouwens; Richard G Ijzerman; Margot M L Linssen; Bruno Guigas; Etto C Eringa; Erik H Serné
Journal:  Diabetologia       Date:  2013-08-11       Impact factor: 10.122

Review 8.  Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.

Authors:  Laurence Fardet; Bruno Fève
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

9.  Cardiovascular autonomic function in Cushing's syndrome.

Authors:  F Fallo; P Maffei; A Dalla Pozza; M Carli; P Della Mea; M Lupia; F Rabbia; N Sonino
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

10.  The calcitonin and glucocorticoids combination: mechanistic insights into their class-effect synergy in experimental arthritis.

Authors:  Adam Al-Kashi; Trinidad Montero-Melendez; Niloufar Moradi-Bidhendi; James P Gilligan; Nozer Mehta; Mauro Perretti
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.